INTEGRATED LABELING SOLUTIONS FOR THE PHARMACEUTICAL INDUSTRY
A small security label on the packaging seals every prescription medicine. In addition to this first-opening protection, the pharmaceutical industry also uses labels for individual marking. Our integrated labeling solutions meet the high requirements of the pharmaceutical industry.
Tamper protection for every medicine
STANDARD-COMPLIANT LABELING OF PHARMACEUTICAL PRODUCTS
Labels are also a suitable solution for serialization and Track & Trace in the pharmaceutical industry. On some packaging, such as glass ampoules, the required data for traceability in accordance with Directive 2011/62/EU is difficult to print directly. In these and many other cases, the necessary 2D-Matrix-Codes and the required product information in plain text can also be applied using labels.
Labels have different functions in the pharmaceutical industry. They serve to convey important product information for pharmacies and patients. They also help to strengthen the image of a product or brand. Special seal labels also serve to protect consumers by ensuring that the respective product is unopened.
What needs to be considered with labeling solutions?
- Legal requirements in accordance with Directive 2011/62/EU
- Fast, economical application
- Good adhesion, permanent readability
- Machine-readable QR code
- Often little space for a lot of information
- Reliable labeling of unusual shapes
Industrial labeling solutions are used throughout the pharmaceutical industry. Labels are applied to secondary packaging made of cardboard, carton, glass and plastic. They support identification, forgery-proofing and consumer protection in the pharmaceutical industry.
Application examples of our labeling solutions
- Fully automatic labeling of primary packaging
- Labelers integrated into production lines for secondary packaging
- Machines for applying sealing labels
Since 2019, prescription-only medicinal products in the European Union have had to be provided with a unique identifier and a device to detect possible tampering in accordance with Directive 2011/62/EU in conjunction with Delegated Regulation (EU) 2016/161. This is intended to protect consumers and manufacturers from counterfeit medicinal products.
